While we have been preoccupied with the effects, good and bad of the COVID-19 vaccines, a new vaccine has recently hit the market: an anti malaria vaccine. The target group for this vaccine is Tropical Africa. Of course, the vaccine is protected by patents, which means that the patent holders have a legal monopoly on the sale of this vaccine for at least 20 years.
The effect of this vaccine will be to drain Africa of significant financial resources which the continent need not spend to control malaria. On the African continent there is a plant , Artemisia Afra, a cousin of Artemisia Annua from China. Herbal teas made from both varieties have been used to treat malaria and flu-like symptoms. Interestingly, the Vietnamese credit Artemisia Annua for turning the tide of the war in Vietnam against the Americans.
Why do we have a Vaccine now against Malaria? Simple. Patents are not granted for discoveries – only inventions. Therefore a vaccine is needed if you want to make money; if a medication is found or invented against Malaria
Only those infected with the parasite would need to take the drug; a vaccine on the other hand could conceivably require every person on earth to be vaccinated. “Mucho Moola”, particularly at a time when private interests have significant power over WHO policies and practices. I am particularly interested in Malaria because I almost died from the disease when I was 5 years old. The probability of a resurgence of malaria is non-zero and we have to be on guard here in Dominica.
Here is a documentary on the Malaria Business on France 24 https://www.youtube.com/watch?v=OvC4uSYprU8&t=4s